Using data from Airfinity, non-profit charity confederation Oxfam has warned that wealthy countries which make up on 13% of the world’s population have already bought up approximately 51% of doses of the five leading Covid-19 vaccine candidates.

This creates a situation, where even if all five vaccines did get approved, almost two-thirds of the world’s population would not have access to a Covid-19 vaccine until 2022 at the earlier.

Oxfam notes that while the UK has managed to secure deals for several leading vaccines candidates, which is the equivalent of five doses per head of the UK population, analysis shows that Bangladesh, for example, has only secured one dose per nine people.

Oxfam health policy advisor Anna Marriott commented: “These figures reveal how pharmaceutical monopolies are being protected at the expense of people’s health and the global economy.

“While countries like the UK are understandably concerned about securing enough doses, until they challenge monopolies these deals will leave many poorer nations out in the cold.

“Most importantly, we will never be able to produce a vaccine at the scale required until corporations share their knowledge free from patents. We need a People’s Vaccine, not a profit vaccine.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Other charitable organisations have also emphasised that the only way to logistically end this pandemic is for Covid-19 vaccines to be available to those at-need, irrespective of where they live.